Roche Molecular

The leading provider of in vitro diagnostics

Roche Molecular, one of four customer-focused areas of Roche Diagnostics Solutions, develops, manufactures and supplies a wide array of innovative molecular diagnostic products, tests, platforms and technologies used to identify and quantify DNA and RNA from different organisms.

The business was founded in the early 1990s following Roche’s investment in polymerase chain reaction (PCR) technology. The mission—enhance the utility of PCR in combatting disease.

The success of researchers, laboratories and point-of-care testing locations relies largely on their ability to efficiently deliver timely, reliable diagnostic results to clinicians and the patients they serve. Our industry-leading systems, broad assay menus, and advanced digital solutions are designed to address real-world needs across the entire healthcare continuum, including oncology, infectious disease and blood screening.

Roche’s leadership and continued advancement of the technique enables PCR to make real differences in the lives of patients, laboratories and healthcare professionals everywhere. Enhancing the management of infectious diseases through early and accurate diagnoses has always been a core organizational focus and continues to define who we are today.

PCR has evolved significantly since its discovery. Today, there exists an entire ecosystem of solutions surrounding the technology. Roche has been the primary driver of this advancement and will continue to invest in PCR innovation going forward. Watch our experts discuss the latest trends in molecular testing.

Learn more about molecular diagnostics

See how our key solutions are impacting the diagnostic world

MWA thumbnail
The Molecular Work Area

 

Transforming your lab and your future is easier than ever. See things differently with Molecular Work Area.

Learn more
Molecular point of care device thumbnail
Molecular Point of Care

 

Roche’s next-generation PCR technology delivers laboratory quality results at the point of care.

Learn more
Auitomated pipetting of lab developed tests
Lab developed tests (LDTs)

 

Delivering innovative lab developed tests is key in helping healthcare institutions defend against outbreaks and manage disease proliferation.

Learn more
Digital diagnostics thumbnail
Digital Diagnostics

 

A suite of specialized solutions that combines innovative technology, data analytics, and deep healthcare expertise to generate actionable insights for meaningful outcomes.

Learn more
Donor screening
Donor screening

 

Since launching the first Nucleic Acid Testing assays for blood screening, Roche has remained committed to keeping the blood supply safe through active surveillance and rapid development of screening solutions.

Learn more
Women health sample graphic
Women’s health

 

From prenatal testing to cervical cancer screening and breast and ovarian cancer diagnosis, our innovative solutions in women’s health empower physicians to provide the right treatment at the right time.

Learn more
Global Access Program
Global Access Program

 

Working hand in hand to provide innovative diagnostics solutions to those who need it most.

Learn more
Donor screening
Sequencing

 

Streamlining workflows and expanding assay menus to accelerate clinical research and cutting-edge diagnostics such as liquid biopsy.

Learn more
Donor screening
Infectious Diseases

 

The growing burden of infectious diseases is impacting the laboratory landscape, make preparedness a priority.

Learn more